Apellis Pharmaceuticals Ownership | Who Owns Apellis Pharmaceuticals?
Apellis Pharmaceuticals Ownership Summary
Apellis Pharmaceuticals is owned by 50.39% institutional investors, 13.93% insiders, and 35.68% retail investors. Avoro capital advisors is the largest institutional shareholder, holding 9.70% of APLS shares. Vanguard Health Care Inv is the top mutual fund, with 6.38% of its assets in Apellis Pharmaceuticals shares.
APLS Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Apellis Pharmaceuticals | 50.39% | 13.93% | 35.68% |
| Sector | Healthcare Stocks | 232.01% | 10.74% | -142.75% |
| Industry | Biotech Stocks | 381.47% | 10.55% | -292.02% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Avoro capital advisors | 12.22M | 9.70% | $276.59M |
| Vanguard group | 10.67M | 8.47% | $268.15M |
| Wellington management group llp | 9.29M | 7.37% | $210.25M |
| Morgan stanley | 9.17M | 7.28% | $230.43M |
| Deep track capital, lp | 8.00M | 6.35% | $181.05M |
| Blackrock funding, inc. /de | 6.26M | 4.97% | $157.25M |
| Blackrock | 5.80M | 4.71% | $222.31M |
| Ubs group | 4.19M | 3.32% | $105.16M |
| State street | 4.04M | 3.20% | $91.37M |
| Ecor1 capital | 3.45M | 2.74% | $78.01M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Deep track capital, lp | 8.00M | 5.05% | $181.05M |
| Ecor1 capital | 3.45M | 3.74% | $78.01M |
| Avoro capital advisors | 12.22M | 3.58% | $276.59M |
| Boxer capital | 1.73M | 3.49% | $66.21M |
| Octagon capital advisors lp | 903.50K | 3.10% | $20.45M |
| Siren | 2.58M | 2.28% | $58.35M |
| Suvretta capital management | 2.88M | 1.67% | $65.13M |
| Ghost tree capital | 135.00K | 1.62% | $5.18M |
| Artal group | 1.47M | 1.43% | $56.28M |
| Camber capital management lp | 850.00K | 1.38% | $14.71M |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Polar capital | 2.65M | 0.29% | 1.30M |
| Norges bank | 1.20M | 0.00% | 1.20M |
| Aqr capital management | 1.86M | 0.08% | 1.04M |
| Deep track capital, lp | 8.00M | 5.05% | 1.00M |
| Bank of nova scotia | 1.46M | 0.06% | 861.41K |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Ecor1 capital | 3.45M | 3.74% | -8.45M |
| Jennison associates | 1.50M | 0.02% | -2.84M |
| Marshall wace, llp | 396.74K | 0.01% | -2.31M |
| Fiera capital | - | - | -1.35M |
| Cibc world markets | - | - | -1.29M |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Norges bank | 1.20M | 0.00% | 1.20M | $30.10M |
| Camber capital management lp | 850.00K | 1.38% | 850.00K | $14.71M |
| Kynam capital management, lp | 808.61K | 1.36% | 808.61K | $18.30M |
| Granite investment partners | 327.09K | 0.49% | 327.09K | $8.22M |
| Cubist systematic strategies | 299.78K | 0.03% | 299.78K | $6.78M |
Sold Out
| Holder | Change |
|---|---|
| Jfs wealth advisors | -1.00 |
| Concourse financial group securities | -1.00 |
| Activest wealth management | -1.00 |
| Wealthspire advisors | -4.00 |
| Creative financial designs inc /adv | -5.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 31, 2025 | 170 | -44.81% | 63,500,120 | -48.18% | 50 | 0.53% | 87 | -44.94% | 54 | -38.64% |
| Sep 30, 2025 | 223 | -14.56% | 85,860,587 | -25.21% | 68 | 0.82% | 108 | -27.52% | 72 | 10.77% |
| Jun 30, 2025 | 273 | -0.36% | 131,534,068 | 4.01% | 104 | 1.03% | 151 | 11.03% | 69 | -13.75% |
| Mar 31, 2025 | 6 | -97.89% | 12,635,786 | -90.03% | 10 | 0.10% | 2 | -98.73% | 1 | -98.68% |
| Dec 31, 2024 | 99 | -66.10% | 25,361,392 | -78.34% | 20 | 0.23% | 57 | -59.57% | 27 | -71.28% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| Vanguard Health Care Inv | 8.15M | 6.38% | 1.82M |
| iShares Core S&P Small-Cap ETF | 6.20M | 4.85% | 6.20M |
| Polar Capital Biotech S Inc | 3.50M | 2.74% | - |
| Vanguard Total Stock Mkt Idx Inv | 3.39M | 2.66% | 9.59K |
| Vanguard US Total Market Shares ETF | 3.30M | 2.63% | 2.68K |
| State Street® SPDR® S&P® Biotech ETF | 2.96M | 2.31% | -15.82K |
| Vanguard Small Cap Index | 2.44M | 1.91% | -1.50K |
| SPDR® S&P Biotech ETF | 1.76M | 1.39% | 3.92K |
| Vanguard Explorer Inv | 1.75M | 1.37% | 753.63K |
| Worldwide Healthcare Ord | 1.51M | 1.18% | - |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Feb 11, 2026 | DeLong Mark Jeffrey | Chief Business & Strat Officer | Sell | $8.15K |
| Jan 22, 2026 | Baumal Caroline | Chief Medical Officer | Sell | $60.88K |
| Jan 22, 2026 | Chopas James George | VP/Chief Accounting Officer | Sell | $44.92K |
| Jan 22, 2026 | DeLong Mark Jeffrey | Chief Business & Strat Officer | Sell | $73.37K |
| Jan 22, 2026 | Deschatelets Pascal | Chief Scientific Officer | Sell | $129.03K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2026 Q1 | - | 25 |
| 2025 Q4 | - | 5 |
| 2025 Q3 | - | 15 |
| 2025 Q2 | - | 1 |
| 2025 Q1 | - | 43 |
APLS Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools